Advanced Enzyme Technologies Ltd Q3 FY25 Results

Summary

Advanced Enzyme Technologies Limited has announced its unaudited financial results for the third quarter and nine months ended December 2024. The company reported a 16% growth in revenue from operations, reaching ₹ 1,691 million. The consolidated EBITDA increased by 30% to ₹ 553 million, and the profit after tax grew by 16% to ₹ 389 million. The human nutrition segment increased by 3% to ₹ 1,018 million, the animal nutrition segment grew by 9% to ₹ 197 million, and the bio-processing segment outperformed by 91% to ₹ 321 million. The total revenue comprises of international sales amounting to ₹ 932 million, a growth of 23%. Domestic sales accounted for ₹ 759 million, a decrease of 2%.

Key Highlights

1. 1

   Revenue from operations grew by 16% to ₹ 1,691 million

2. 2

   Consolidated EBITDA increased by 30% to ₹ 553 million

3. 3

   Profit after tax grew by 16% to ₹ 389 million

4. 4

   Human nutrition segment increased by 3% to ₹ 1,018 million

5. 5

   Animal nutrition segment grew by 9% to ₹ 197 million

6. 6

   Bio-processing segment outperformed by 91% to ₹ 321 million

7. 7

   International sales grew by 23% to ₹ 932 million

8. 8

   Domestic sales accounted for ₹ 759 million, a decrease of 2%